Dihydropyridine calcium antagonists: the role in current therapy of cardio-vascular diseases

被引：0
|
作者：
Shilova, E. V. [1 ]
Martsevich, S. Y. [1 ]
机构：
[1] State Res Ctr prevent Med Rosmedtechnol, Moscow, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2008年 / 4卷 / 02期
关键词：
calcium antagonists; dihydropiridines; arterial hypertension; ischemic heart disease; cardiovascular risk; amlodipine;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Classification of calcium antagonists (CA) is presented. Results of the large clinical trials (STONE, STOP-Hypertension-2, ALLHAT, ASCOT-BPLA etc.) devoted to estimation of CA effects on the risk of cardiovascular complications are analyzed. The significant place of dihydropyridine CA in current guidelines on arterial hypertension and ischemic heart disease therapy is underlined. Results of a pilot study on comparison of two amlodipines (original Norvasc and generic Stamlo M) are discussed.
引用
收藏
页码：53 / 57
页数：5
相关论文
共 50 条
  • [21] The SAPALDIA cohort: design and results in the field of respiratory and cardio-vascular diseases
    T Rochat
    BMC Proceedings, 7 (Suppl 5)
  • [22] Heart failure therapy based on interventricular mechanics and cardio-vascular communications
    Schranz, Dietmar
    Akintuerk, Hakan
    Esmaeili, Anoosh
    Latus, Heiner
    Apitz, Christian
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2021, 11 (04) : 1080 - 1088
  • [23] Psychological risk factors in anxiety and depression symptoms in patients with cardio-vascular diseases
    Aleksovska, L.
    Vujovic, V.
    Gerazova, V.
    Arsova, S.
    Ristovska-Dimova, T.
    Dojcinovski, I.
    Hadzi-Angelkovski, G.
    Mitrev, Z.
    EUROPEAN PSYCHIATRY, 2007, 22 : S214 - S215
  • [24] FACTORS INFLUENCING THE PRODUCTION OF CARDIO-VASCULAR DISEASES BY ANTERIOR PITUITARY AND CORTICOID HORMONES
    SELYE, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1946, 6 (06): : 471 - 471
  • [25] Function and regulation of the Cav1.2 calcium channel in the cardio-vascular system
    Domes, K.
    Blaich, A.
    Lemke, T.
    Welling, A.
    Moosmang, S.
    Hofmann, F.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 52 - 53
  • [26] Building an ontology of cardio-vascular diseases for concept-based information retrieval
    Gedzelman, S
    Simonet, M
    Bernhard, D
    Diallo, G
    Palmer, P
    Computers in Cardiology 2005, Vol 32, 2005, 32 : 255 - 258
  • [27] Cardio-vascular diseases among people with intellectual disabilities: rare, forgotten or overlooked?
    Plasil, Tanja
    Oldervoll, Line
    Berge, Kim
    Ersfjord, Ellen
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2021, 49 (1_SUPPL) : 25 - 26
  • [28] Is there a true place for omega 3 fatty acids to prevent cardio-vascular diseases?
    Dallongeville, Jean
    ANNALS OF NUTRITION AND METABOLISM, 2015, 67 : 46 - 47
  • [29] RESULTS AND ROUTES OF FURTHER DEVELOPMENT OF SCIENTIFIC RESEARCH IN DOMAIN OF CARDIO-VASCULAR DISEASES
    CHAZOV, EI
    ELISEEV, OM
    TERAPEVTICHESKII ARKHIV, 1976, 48 (01) : 3 - 14
  • [30] THE ROLE OF A NURSE-CLINIC IN THE ASSESSMENT AND PREVENTION OF CARDIO-VASCULAR RISK
    Martinez Alberola, N.
    Sivera, F.
    Andres, M.
    Fernandez-Carballido, C.
    Martin-Domenech, R.
    Martinez-Vidal, M. P.
    San Martin-Alvarez, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 121 - 121
12345